Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 02, 2025

Get In Touch

JnJ seeks USFDA nod for Stelara in treatment of pediatric ulcerative colitis Pharma News

JnJ seeks USFDA nod for Stelara in treatment of pediatric ulcerative colitis

  • 01 November 2025
  • 1 day ago

Birds, Lizards, and Broken Protocols: USFDA Slams Hetero Labs Over Filthy Warehouse, Missing Records Pharma News

Birds, Lizards, and Broken Protocols: USFDA Slams Hetero Labs Over Filthy Warehouse, Missing Records

  • 31 October 2025
  • 1 day ago

Zydus receives USFDA EIR for Baddi facility Pharma News

Zydus receives USFDA EIR for Baddi facility

  • 30 October 2025
  • 3 days ago

FDA Expands Indication for Sotatercept-csrk in Pulmonary Arterial Hypertension Pulmonology

FDA Expands Indication for Sotatercept-csrk in Pulmonary Arterial Hypertension

  • 29 October 2025
  • 3 days ago

FDA Approves Obinutuzumab for Active Lupus Nephritis Nephrology

FDA Approves Obinutuzumab for Active Lupus Nephritis

  • 29 October 2025
  • 3 days ago

Alembic Pharma wins USFDA nod for heart disease drug Pharma News

Alembic Pharma wins USFDA nod for heart disease drug

  • 29 October 2025
  • 4 days ago

Granules India gets USFDA EIR for Bonthapally facility Pharma News

Granules India gets USFDA EIR for Bonthapally facility

  • 29 October 2025
  • 4 days ago

Eli Lilly Omvoh secures USFDA approval as single-injection maintenance regimen in adults with ulcerative colitis Pharma News

Eli Lilly Omvoh secures USFDA approval as single-injection maintenance regimen in adults with ulcerative colitis

  • 28 October 2025
  • 4 days ago

USFDA nod to updated indication for Winrevair in adults with Pulmonary Arterial Hypertension Pharma News

USFDA nod to updated indication for Winrevair in adults with Pulmonary Arterial Hypertension

  • 28 October 2025
  • 4 days ago

Cohance Lifesciences Nacharam facility gets OAI status from USFDA Pharma News

Cohance Lifesciences Nacharam facility gets OAI status from USFDA

  • 27 October 2025
  • 6 days ago

Recent News

Himachal notifies Resident doctor policy 2025

  • 02 November, 2025

Pfizer files lawsuit against Metsera, its Director...

  • 02 November, 2025

Health Ministry achieves 3 Guinness World Records...

  • 02 November, 2025

Roche gets CE mark for Elecsys Dengue Ag test to d...

  • 02 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.